Evidence map›Paper›PMID 42347031›Full record

ArticleMethods and protocols2026

The ADAPT-HEAT Study: A Multi-Method Approach to Develop Recommendations for Drug Safety During Hot Weather (The CALOR List)-Study Protocol.

Maxie Bunz, Pascal Nohl-Deryk, Heike van de Sand, Katharina van Baal, Svenja Arendt, Alina Herrmann, Ingo Meyer, Adriana Poppe, Olaf Krause, Johannes Heck and 1 more

Abstract read
In one paragraph

Article in Methods and protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maxie BunzInstitute of General Practice, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Pascal Nohl-DerykInstitute of General Practice, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0002-5350-2018
Heike van de SandHealth Department, City of Cologne, 50667 Cologne, Germany.
Katharina van BaalInstitute for General Practice and Palliative Care, Hannover Medical School (MHH), 30625 Hannover, Germany.ORCID 0000-0002-2425-3710
Svenja ArendtInstitute for General Practice and Palliative Care, Hannover Medical School (MHH), 30625 Hannover, Germany.ORCID 0000-0003-4643-8131
Alina HerrmannInstitute of General Practice, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Ingo MeyerPMV Research Group, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0001-8515-8285
Adriana PoppePMV Research Group, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0002-6067-6411
Olaf KrauseInstitute for General Practice and Palliative Care, Hannover Medical School (MHH), 30625 Hannover, Germany.
Johannes HeckInstitute for General Practice and Palliative Care, Hannover Medical School (MHH), 30625 Hannover, Germany.ORCID 0000-0002-5382-3014
Beate Sigrid MüllerInstitute of General Practice, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0002-6745-1047

Funding

Gemeinsamer Bundesausschuss 01VSF23016
6 · The paper itself

Abstract

Certain medications may adversely affect health during hot days and heatwaves by altering chronic conditions, comorbidities, fluid balance, or impairing heat adaptation. This study aims to develop evidence-based cross-sectoral recommendations for the safe administration of heat-sensitive medications, compiled into a so-called 'CALOR' list (calor: Latin for 'heat'). Development of the CALOR list will follow a four-pillar process. First, a scoping review of scientific literature and best practices will identify potentially inadequate medications during heat events (heat-PIMs) and adaptation measures, resulting in a first draft. Second, an expert panel will refine this draft through a Delphi process to reach consensus on clinically relevant recommendations. Third, German statutory health insurance (SHI) claims data will be analysed to determine heat-PIMs prevalence; data from Cologne residents will additionally be linked with climate data to investigate health outcomes during heat events. Fourth, thirty health professionals (i.e., medical doctors, nurses, pharmacists) will field-test the CALOR list in summer, providing qualitative feedback on feasibility, leading to further refinement of the CALOR list. To our knowledge this study protocol presents the first study attempting to collate a comprehensive and actionable list of recommendations for drug safety management during hot days and heatwaves.

Indexed as

clinical protocolsextreme heathot temperaturepatient safetypotentially inappropriate medication list

Identifiers

PMID42347031
PMCPMC13305179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.